Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

ABSTRACT:

SUBMITTER: Oza AM 

PROVIDER: S-EPMC4648090 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature